Statement of Changes in Beneficial Ownership (4)

FORM 4

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden
hours per response...

0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Weissman Kenneth Ian	2. Issuer Name and Ticker or Trading Symbol IMAX CORP [ IMAX ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) Sr VP & Corporate Secretary
(Last)          (First)          (Middle) 902 BROADWAY, 20TH FLOOR	3. Date of Earliest Transaction (MM/DD/YYYY) 12/1/2020
(Street) NEW YORK, NY 10010-6002 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
common shares (opening balance)								7820	D
common shares	12/1/2020		M		867 (1)	A	$0.00	8687	D
common shares	12/1/2020		F		295 (2)	D	$15.13	8392	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
restricted share units (3)	$0.00 (4)	12/1/2020		M			867 (1)	(5)	(5)	common shares	867	$0.00 (4)	0 (6)	D

Explanation of Responses:
(1)	Represents the conversion upon vesting of restricted share units into common shares.
(2)	Mr. Weissman is reporting the withholding of common shares to satisfy the tax withholding obligations in connection with the delivery of common shares upon conversion of the restricted share units.
(3)	Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation.
(4)	Each restricted share unit is the economic equivalent of one common share of IMAX Corporation.
(5)	The restricted share units vested and converted to common shares in four installments: 20% of the initial grant on the first anniversary of the grant date, 25% of the initial grant on each of the second and third anniversaries of the grant date and 30% of the initial grant on December 1 of the third year after the grant date.
(6)	This represents the number of restricted share units for this transaction only. Mr. Weissman's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 26,239; 19,399 and 8,392, respectively.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Weissman Kenneth Ian 902 BROADWAY 20TH FLOOR NEW YORK, NY 10010-6002			Sr VP & Corporate Secretary

Signatures
/s/ Kenneth Ian Weissman		12/3/2020
**Signature of Reporting Person		Date